Published in Mol Endocrinol on May 14, 2009
Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology (2012) 3.98
Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation. Nat Struct Mol Biol (2012) 1.15
Androgen receptor gene rearrangements: new perspectives on prostate cancer progression. Curr Drug Targets (2013) 0.85
1-Carbon Cycle Metabolites Methylate Their Way to Fatty Liver. Trends Endocrinol Metab (2016) 0.75
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers (1983) 99.69
Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49
The steroid and thyroid hormone receptor superfamily. Science (1988) 25.68
Development and testing of a general amber force field. J Comput Chem (2004) 23.29
Force fields for protein simulations. Adv Protein Chem (2003) 8.70
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
Molecular biology of the androgen receptor. J Clin Oncol (2002) 5.08
Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev (1995) 4.22
Androgen receptor (AR) coregulators: an overview. Endocr Rev (2002) 4.01
Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev (2004) 3.74
Structural basis for antagonism and resistance of bicalutamide in prostate cancer. Proc Natl Acad Sci U S A (2005) 2.89
Atomic structure of progesterone complexed with its receptor. Nature (1998) 2.83
Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol (1998) 2.55
Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol (1991) 2.54
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci U S A (2001) 2.44
Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res (1997) 2.41
Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (1998) 2.31
Pressure-induced reversible dissociation of enolase. Biochemistry (1981) 2.17
Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J Biol Chem (1999) 2.00
A surface on the androgen receptor that allosterically regulates coactivator binding. Proc Natl Acad Sci U S A (2007) 1.97
Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol (2004) 1.91
The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Biochemistry (2007) 1.81
The structure of the nuclear hormone receptors. Steroids (1999) 1.80
Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem (1992) 1.73
Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun (1988) 1.64
Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation. J Mol Biol (2000) 1.53
Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol (2000) 1.50
Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci U S A (1997) 1.50
Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone. J Biol Chem (2007) 1.47
Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J Biol Chem (2002) 1.41
Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem (2003) 1.39
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs. Mol Cell Biol (2003) 1.24
Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study. J Pharm Sci (2003) 1.21
Determination of tyrosine exposure in proteins by second-derivative spectroscopy. Biochemistry (1984) 1.21
Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation. Mol Endocrinol (2005) 1.17
Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Sci (2006) 1.15
Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display. Mol Endocrinol (2005) 1.14
The rat androgen receptor: primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Mol Endocrinol (1988) 1.13
NMR relaxation study of the complex formed between CBP and the activation domain of the nuclear hormone receptor coactivator ACTR. Biochemistry (2008) 1.12
Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators. Mol Endocrinol (2006) 1.11
Probing conformational changes in the estrogen receptor: evidence for a partially unfolded intermediate facilitating ligand binding and release. Mol Endocrinol (2001) 1.10
Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. J Biol Chem (2006) 1.08
Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction. Ann N Y Acad Sci (2001) 1.06
Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity. J Biol Chem (2005) 1.04
Evaluation of ligand-dependent changes in AR structure using peptide probes. Mol Endocrinol (2002) 1.02
An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors. J Biol Chem (1999) 1.00
Protein stability induced by ligand binding correlates with changes in protein flexibility. Protein Sci (2003) 1.00
Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design. J Biol Chem (2007) 0.96
Folding of a pressure-denatured model protein. Proc Natl Acad Sci U S A (1999) 0.95
Molecular action of androgens. Mol Cell Endocrinol (2002) 0.94
Simultaneous monitoring of the environment of tryptophan, tyrosine, and phenylalanine residues in proteins by near-ultraviolet second-derivative spectroscopy. Anal Biochem (1994) 0.93
Pressure-jump studies of the folding/unfolding of trp repressor. J Mol Biol (1999) 0.90
Double point mutant F34W/W140F of staphylococcal nuclease is in a molten globule state but highly competent to fold into a functional conformation. J Biochem (2000) 0.86
Mechanism of antiandrogen action: conformational changes of the receptor. Mol Cell Endocrinol (1994) 0.86
Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling. Biochemistry (2004) 0.86
Tetrahydrogestrinone is an androgenic steroid that stimulates androgen receptor-mediated, myogenic differentiation in C3H10T1/2 multipotent mesenchymal cells and promotes muscle accretion in orchidectomized male rats. Endocrinology (2005) 0.85
Structure and function of the androgen receptor. Urol Res (1989) 0.83
The androgen receptor: functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines. J Steroid Biochem Mol Biol (1990) 0.83
Protein folding in the absence of chemical denaturants. Reversible pressure denaturation of the noncovalent complex formed by the association of two protein fragments. J Biol Chem (1999) 0.82
Effects of androgens and antiandrogens on the conformation of the androgen receptor. Ann N Y Acad Sci (1995) 0.80
Simultaneous determination of tyrosine and tryptophan residues in proteins by second-derivative spectroscopy. Anal Biochem (1982) 0.79
Quantitative analysis of protein mixtures by second derivative absorption spectroscopy. Anal Biochem (1989) 0.76
Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med (2009) 7.55
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med (2012) 4.18
A structural state of the myosin V motor without bound nucleotide. Nature (2003) 3.63
Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab (2004) 3.45
Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2010) 3.40
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci (2005) 3.14
Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol (2008) 2.82
The structure of the myosin VI motor reveals the mechanism of directionality reversal. Nature (2005) 2.50
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab (2004) 2.35
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Probalign: multiple sequence alignment using partition function posterior probabilities. Bioinformatics (2006) 2.13
Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 2.08
Critical illness in children with influenza A/pH1N1 2009 infection in Canada. Pediatr Crit Care Med (2010) 2.08
Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain (2015) 2.01
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab (2003) 1.98
Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.91
Ascertainment of Testosterone Prescribing Practices in the VA. Med Care (2015) 1.89
Myosin IIIa boosts elongation of stereocilia by transporting espin 1 to the plus ends of actin filaments. Nat Cell Biol (2009) 1.83
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab (2007) 1.77
Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology (2003) 1.74
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab (2003) 1.74
Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab (2011) 1.71
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract (2004) 1.69
Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol (2011) 1.65
A survey of stated physician practices and beliefs on the use of steroids in pediatric fluid and/or vasoactive infusion-dependent shock. Pediatr Crit Care Med (2013) 1.63
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab (2010) 1.62
Targeting the skeletal muscle-metabolism axis in prostate-cancer therapy. N Engl J Med (2012) 1.61
Influence of sex and hormone status on circulating natriuretic peptides. J Am Coll Cardiol (2011) 1.61
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care (2011) 1.60
Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery (2008) 1.58
Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab (2003) 1.57
Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology (2005) 1.56
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab (2002) 1.54
Quality of reporting of surveys in critical care journals: a methodologic review. Crit Care Med (2012) 1.53
The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab (2007) 1.53
Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51
Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke's cleft cysts, craniopharyngiomas, and meningiomas. Surg Neurol (2008) 1.50
Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab (2011) 1.50
DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination. Mitochondrion (2009) 1.50
Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab (2010) 1.50
Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children. Cochrane Database Syst Rev (2014) 1.49
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss. Am J Physiol Endocrinol Metab (2008) 1.46
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Genetic determinants of serum testosterone concentrations in men. PLoS Genet (2011) 1.45
Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial. J Gerontol A Biol Sci Med Sci (2013) 1.44
Androgen supplementation in older women: too much hype, not enough data. J Am Geriatr Soc (2002) 1.43
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2011) 1.43
Low-fat high-fiber diet decreased serum and urine androgens in men. J Clin Endocrinol Metab (2005) 1.42
Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIb. Biochemistry (2004) 1.40
Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab (2009) 1.40
Testosterone administration decreases generosity in the ultimatum game. PLoS One (2009) 1.40
Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab (2006) 1.40
Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J Immunol (2006) 1.39
Tests of muscle strength and physical function: reliability and discrimination of performance in younger and older men and older men with mobility limitations. J Am Geriatr Soc (2008) 1.37
Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab (2004) 1.36
Activation of phasic pontine-wave generator prevents rapid eye movement sleep deprivation-induced learning impairment in the rat: a mechanism for sleep-dependent plasticity. J Neurosci (2004) 1.36
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev (2013) 1.33
Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab (2003) 1.33
The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem (2008) 1.32
Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care (2004) 1.32
Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab (2006) 1.31
Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet (2011) 1.30
Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet (2006) 1.30
Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab (2005) 1.28
Predicting protein functional sites with phylogenetic motifs. Proteins (2005) 1.25
Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men. J Am Geriatr Soc (2008) 1.24
Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc (2007) 1.24
A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet (2012) 1.23
Klinefelter syndrome: expanding the phenotype and identifying new research directions. Genet Med (2003) 1.21
Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab (2004) 1.21
The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol (2006) 1.20
The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab (2002) 1.20
Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology (2008) 1.20
Hypothermia therapy after pediatric cardiac arrest. Circulation (2009) 1.19
Habitual physical activity levels are associated with performance in measures of physical function and mobility in older men. J Am Geriatr Soc (2010) 1.19